CCO Treatment Updates
Class in Session: Defining the Role of the Newest Class of Antiretrovirals
Video Module
Class in Session: Defining the Role of the Newest Class of Antiretrovirals
|
Program Director: Paul E. Sax, MD
  
- Joseph J. Eron, Jr., MD
- Richard Haubrich, MD
- Daniel R. Kuritzkes, MD
|
|
|
Joseph J. Eron Jr., MD; Richard Haubrich, MD; Daniel R. Kuritzkes, MD; and Paul E. Sax, MD, discuss the science behind the use of integrase inhibitors, clinical studies of integrase inhibitors, and the role of these agents in managing HIV-infected patients.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recount findings from basic science that are relevant to the clinical use of integrase inhibitors, including their mechanism of action and the selection of viral resistance
- Describe the results of clinical studies of integrase inhibitors in both treatment-naive and treatment-experienced patient populations including a comparison of these results with those of alternative agents
- Summarize ongoing studies to elucidate the role of integrase inhibitors in novel therapeutic strategies
- Discuss practical strategies to optimize virologic outcomes in patients in whom use of an integrase inhibitor is being considered
|
CCO Slidesets
The Science of Integrase Strand Transfer Inhibitors (INSTIs): New Insights and Clinical Implications
 |
|
This downloadable slideset reviews the science behind integrase inhibitors, including a discussion of relevant drug-drug interactions.
Format: Microsoft PowerPoint (.ppt) |
File size: 810 KB
| Date posted: 9/17/2009
|
Studies of Integrase Inhibitors Across the Treatment Spectrum
 |
|
This downloadable slideset reviews the latest clinical data on integrase inhibitors.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.33 MB
| Date posted: 9/18/2009
|
The Current Role of Integrase Inhibitors in Clinical Practice
 |
|
This downloadable slideset reviews practical strategies for using integrase inhibitors in clinical practice.
Format: Microsoft PowerPoint (.ppt) |
File size: 614 KB
| Date posted: 9/17/2009
|
Video Segments
The Science of Integrase Strand Transfer Inhibitors: New Insights and Clinical Implications
Now Playing...
Joseph J. Eron Jr., MD; Richard Haubrich, MD; Daniel R. Kuritzkes, MD; and Paul E. Sax, MD, discuss the science behind the use of integrase inhibitors...
Studies of Integrase Inhibitors Across the Treatment Spectrum
Now Playing...
Joseph J. Eron Jr., MD; Richard Haubrich, MD; Daniel R. Kuritzkes, MD; and Paul E. Sax, MD, discuss the science behind the use of integrase inhibitors, clinical studies of integrase inhibitors, and the role of these agents in managing HIV-infected patients.
The Current Role of Integrase Inhibitors in Clinical Practice
Now Playing...
Joseph J. Eron Jr., MD; Richard Haubrich, MD; Daniel R. Kuritzkes, MD; and Paul E. Sax, MD, discuss the science behind the use of integrase inhibitors, clinical studies of integrase inhibitors, and the role of these agents in managing HIV-infected patients.
Case Discussions: Considerations of Using an Integrase Inhibitor in a Naive and Experienced Patients
Now Playing...
Joseph J. Eron Jr., MD; Richard Haubrich, MD; Daniel R. Kuritzkes, MD; and Paul E. Sax, MD, discuss the science behind the use of integrase inhibitors...
Mouse over thumbnails for more information on the segments
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|